Synthesit Oxygen Force, an innovative supplement producer, will introduce its partner program at the White Label World Expo, held at the Javits Center, New York, on September 29-30. The brand, available in the U.S., Canada, Japan, and EU, aims to expand its North American distribution through local partners.
A unique mineral based on iron, Synthesit Oxygen Force 1000TM is produced by a state-of-the-art process that replicates the extreme temperatures of natural geothermal activity. This innovative method yields a young mineral with outstanding qualities for human health. Minerals with similar qualities can be found in micro-concentrations around volcano-rich regions and seismically active areas.
Synthesit Oxygen Force 1000TM boosts the body’s production of blood stem cells. This increases blood oxygen levels (SpO2) up to 100% and restores healthy blood viscosity, which is key for deep tissue rejuvenation. Synthesit also reduces heart disease risk factors, including blood pressure, and helps to manage chronic fatigue and stress.
The supplement improves circulation and blood flow, supplying all organs and tissues with oxygen and essential nutrients to maintain proper function, improving holistic microcirculation throughout the skin, muscles, and brain. As a result, it helps enhance athletic performance, support active lifestyle and exercise routine.
Synthesit Oxygen Force 1000TM reduces the activity of ADA and XO enzymes/aging markers by 2x, while upregulating Klotho gene — a natural human protein with great potential to delay diseases of aging — by 1.9x.
The mineral brings the body into homeostatic balance, so it can stabilize iron, hemoglobin, and ferritin levels if any deficiency is present. Synthesit does not increase normal levels of iron.
The new White Label Program will allow health and wellness companies to advance their offerings and utilize the power of Synthesit state-of-the-art production. The company’s partners in Japan and Europe include producers of superfoods, vitamins, essential oils, and more.
SynthesitTM products have been on the market in the EU, Japan, and North America since 2020, available for order on the company’s website, as well as Amazon and other marketplaces. The health startup, launched in 2020, generates more than $3 million in sales around the globe. SynthesitTM R&D began in 2015 and took over five years to reach its present stage of development. The product was developed in cooperation with CERN consultants, the world’s largest scientific research center. In the U.S., it is produced in an FDA-approved facility. This year, the company launched its clinical trials in Israel. SynthesitTM is certified by The German Sport University Cologne as non-doping, which also means no substances listed or banned by WADA are involved at any stage of its production.